DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Meprobamate (Meprobamate) - Summary

 
 



MEPROBAMATE SUMMARY

Meprobamate is a white powder with a characteristic odor and a bitter taste. It is slightly soluble in water, freely soluble in acetone and alcohol, and sparingly soluble in ether.

Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.

The effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.


See all Meprobamate indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Meprobamate

Women with mild heart blockage report poorer health, more anxiety and negativity than men
Source: Anxiety / Stress News From Medical News Today [2017.02.21]
Women with mild blockage of coronary arteries report poorer health, more anxiety and a more negative outlook than men with the same condition, according to new research in the American Heart...

Depression or anxiety may increase risk of surgical wound complications
Source: Anxiety / Stress News From Medical News Today [2017.02.20]
Patients' mental health may affect their risk of experiencing wound-related complications after surgery, new research indicates.

Researchers discover how the brain turns chronic stress into pathological anxiety
Source: Anxiety / Stress News From Medical News Today [2017.02.16]
In a new study, researchers at The Scripps Research Institute (TSRI) have described how two important molecules in the brain work together to trigger intense anxiety.

Anxiety and depression may be linked to increased risk of death from some cancers
Source: Anxiety / Stress News From Medical News Today [2017.01.27]
A study published by The BMJ suggests that higher levels of psychological distress (anxiety and depression) may be associated with an increased risk of death from certain cancers.

Anxiety May Lead to Unneeded Prostate Cancer Treatments
Source: MedicineNet Prostate Cancer Specialty [2017.01.27]
Title: Anxiety May Lead to Unneeded Prostate Cancer Treatments
Category: Health News
Created: 1/27/2017 12:00:00 AM
Last Editorial Review: 1/27/2017 12:00:00 AM

more news >>

Published Studies Related to Meprobamate

Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital. [2003.06]
Implementation of regulations to control the prescribing of benzodiazepines in New York State in 1989 resulted in a 55% decrease in benzodiazepine prescribing, with a concomitant increase in the rates of prescribing older sedative-hypnotic compounds such as butabarbital (30% increase) and meprobamate (125% increase).

more studies >>

Reports of Suspected Meprobamate Side Effects

Toxicity TO Various Agents (28)Respiratory Arrest (15)Cardiac Arrest (15)Accidental Death (14)Drug Abuse (11)Completed Suicide (11)Death (5)Multiple Drug Overdose Accidental (5)Pulmonary Congestion (5)Pulmonary Oedema (4)more >>


Page last updated: 2017-02-21

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015